154 related articles for article (PubMed ID: 18949455)
21. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways.
Liu L; Li F; Cardelli JA; Martin KA; Blenis J; Huang S
Oncogene; 2006 Nov; 25(53):7029-40. PubMed ID: 16715128
[TBL] [Abstract][Full Text] [Related]
22. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
Han S; Khuri FR; Roman J
Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
[TBL] [Abstract][Full Text] [Related]
23. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.
Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG
Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784
[TBL] [Abstract][Full Text] [Related]
24. Dominant-negative suppression of HNF-1alpha function results in defective insulin gene transcription and impaired metabolism-secretion coupling in a pancreatic beta-cell line.
Wang H; Maechler P; Hagenfeldt KA; Wollheim CB
EMBO J; 1998 Nov; 17(22):6701-13. PubMed ID: 9822613
[TBL] [Abstract][Full Text] [Related]
25. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).
Friedrichsen BN; Galsgaard ED; Nielsen JH; Møldrup A
Mol Endocrinol; 2001 Jan; 15(1):136-48. PubMed ID: 11145745
[TBL] [Abstract][Full Text] [Related]
26. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
[TBL] [Abstract][Full Text] [Related]
27. Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes.
Harries LW; Ellard S; Stride A; Morgan NG; Hattersley AT
Hum Mol Genet; 2006 Jul; 15(14):2216-24. PubMed ID: 16760222
[TBL] [Abstract][Full Text] [Related]
28. Sirtuin 1 independent effects of resveratrol in INS-1E β-cells.
Erdogan CS; Mørup-Lendal M; Dalgaard LT; Vang O
Chem Biol Interact; 2017 Feb; 264():52-60. PubMed ID: 28108221
[TBL] [Abstract][Full Text] [Related]
29. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes.
Veilleux A; Houde VP; Bellmann K; Marette A
Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102
[TBL] [Abstract][Full Text] [Related]
30. Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins.
Wang X; Beugnet A; Murakami M; Yamanaka S; Proud CG
Mol Cell Biol; 2005 Apr; 25(7):2558-72. PubMed ID: 15767663
[TBL] [Abstract][Full Text] [Related]
31. Regulation of cyclin D1 expression by mTORC1 signaling requires eukaryotic initiation factor 4E-binding protein 1.
Averous J; Fonseca BD; Proud CG
Oncogene; 2008 Feb; 27(8):1106-13. PubMed ID: 17724476
[TBL] [Abstract][Full Text] [Related]
32. Iron depletion suppresses mTORC1-directed signalling in intestinal Caco-2 cells via induction of REDD1.
Watson A; Lipina C; McArdle HJ; Taylor PM; Hundal HS
Cell Signal; 2016 May; 28(5):412-424. PubMed ID: 26827808
[TBL] [Abstract][Full Text] [Related]
33. AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis.
Mi W; Ye Q; Liu S; She QB
Oncotarget; 2015 Jun; 6(16):13962-77. PubMed ID: 25961827
[TBL] [Abstract][Full Text] [Related]
34. HNF1α controls glucagon secretion in pancreatic α-cells through modulation of SGLT1.
Sato Y; Rahman MM; Haneda M; Tsuyama T; Mizumoto T; Yoshizawa T; Kitamura T; Gonzalez FJ; Yamamura KI; Yamagata K
Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165898. PubMed ID: 32711050
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia-induced endothelial proliferation requires both mTORC1 and mTORC2.
Li W; Petrimpol M; Molle KD; Hall MN; Battegay EJ; Humar R
Circ Res; 2007 Jan; 100(1):79-87. PubMed ID: 17110594
[TBL] [Abstract][Full Text] [Related]
36. Prion formation correlates with activation of translation-regulating protein 4E-BP and neuronal transcription factor Elk1.
Allard EK; Grujic M; Fisone G; Kristensson K
Neurobiol Dis; 2013 Oct; 58():116-22. PubMed ID: 23742760
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of insulin signaling and adipogenesis by rapamycin: effect on phosphorylation of p70 S6 kinase vs eIF4E-BP1.
El-Chaâr D; Gagnon A; Sorisky A
Int J Obes Relat Metab Disord; 2004 Feb; 28(2):191-8. PubMed ID: 14970836
[TBL] [Abstract][Full Text] [Related]
38. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia.
Colclough K; Bellanne-Chantelot C; Saint-Martin C; Flanagan SE; Ellard S
Hum Mutat; 2013 May; 34(5):669-85. PubMed ID: 23348805
[TBL] [Abstract][Full Text] [Related]
39. Chronic paraplegia-induced muscle atrophy downregulates the mTOR/S6K1 signaling pathway.
Dreyer HC; Glynn EL; Lujan HL; Fry CS; DiCarlo SE; Rasmussen BB
J Appl Physiol (1985); 2008 Jan; 104(1):27-33. PubMed ID: 17885021
[TBL] [Abstract][Full Text] [Related]
40. EGF-induced activation of Akt results in mTOR-dependent p70S6 kinase phosphorylation and inhibition of HC11 cell lactogenic differentiation.
Galbaugh T; Cerrito MG; Jose CC; Cutler ML
BMC Cell Biol; 2006 Sep; 7():34. PubMed ID: 16984645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
